# LUMYBI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lumybi

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Angel (Sep 16, 2021)
- Investors on record: 2

## About

Based in Shanghai, China, and founded in 2021, LUMYBI operates as a biotechnology service provider focusing on light-driven CO2 recovery. The core R&D team has more than ten years of technology accumulation in photosynthetic biomodification, artificial photosynthetic colony development, and metabolic modeling.

The company focuses on the areas of functional active ingredients, healthcare nutrition, and sustainable agriculture. It has developed various synthetic biology technologies, such as the DTL-B synthetic biology paradigm of cofactor self-cycling Cell-free to improve the throughput and automation of cellular metabolic pathway modification, and DeepMARS, a pathway hyper-speed optimization system based on AI molecular structure tools for the design of catalytic molecular machines.

## Funding rounds

- Angel, Sep 16, 2021 — Taiyou Fund, Innoangel Fund

## Investors

- Taiyou Fund — Angel
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Angel